AEON Biopharma (AEON) Total Current Liabilities (2020 - 2026)
AEON Biopharma (AEON) posted Total Current Liabilities of $6.9 million for Q4 2025, down 16.18% sequentially from $8.2 million in Q3 2025, and down 51.25% YoY from $14.1 million in Q4 2024.
AEON Biopharma (AEON) Total Current Liabilities (2020 - 2026) Analysis & Trends
AEON Biopharma has reported Total Current Liabilities for 6 years, with the latest figure at $6.9 million in Q4 2025.
- Quarterly Total Current Liabilities fell 51.25% year-over-year to $6.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.9 million (down 51.25% YoY) and the FY2025 annual result came in at $6.9 million, down 51.25% from the prior year.
- Total Current Liabilities retreated to $6.9 million in Q4 2025 per AEON's latest filing, from $8.2 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $82.6 million in Q4 2022 and troughed at $206445.0 in Q2 2021.
- A 5-year average of $10.7 million and a median of $8.4 million in 2025 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2023: Total Current Liabilities surged 9794.02% in 2022, then sank 84.2% in 2023.
- Over 5 years, Total Current Liabilities stood at $834585.0 in 2021, then soared by 9794.02% to $82.6 million in 2022, then tumbled by 84.2% to $13.0 million in 2023, then grew by 8.43% to $14.1 million in 2024, then tumbled by 51.25% to $6.9 million in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $6.9 million, $8.2 million, and $9.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.51 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 438.74 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 630.93 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 2.49 Bn |
| 10 | AEON Biopharma | 10.06 Mn | 6.62 Mn | - | 7.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.34 Mn |
| Dec 31, 2025 | 6.90 Mn |
| Sep 30, 2025 | 8.23 Mn |
| Jun 30, 2025 | 9.13 Mn |
| Mar 31, 2025 | 8.64 Mn |
| Dec 31, 2024 | 14.15 Mn |
| Sep 30, 2024 | 10.73 Mn |
| Jun 30, 2024 | 10.43 Mn |
| Mar 31, 2024 | 15.96 Mn |
| Dec 31, 2023 | 13.05 Mn |
| Sep 30, 2023 | 14.18 Mn |
| Jun 30, 2023 | 9.46 Mn |
| Mar 31, 2023 | 5.87 Mn |
| Dec 31, 2022 | 82.57 Mn |
| Sep 30, 2022 | 1.35 Mn |
| Jun 30, 2022 | 965,778.00 |
| Mar 31, 2022 | 791,843.00 |
| Dec 31, 2021 | 834,585.00 |
| Sep 30, 2021 | 223,495.00 |
| Jun 30, 2021 | 206,445.00 |